SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Related Articles
Cancer Screening
Cancer screening is checking for cancer in people who don’t have symptoms. Screening tests can help doctors find and treat several types of cancer early,…
Cancer Statistics
Reports on U.S. cancer statistics, educational resources, web-based interactive tools, maps, and graphs, publications, videos, and twitter.
NIH study investigates trends in early-onset cancers
An analysis by NIH researchers finds that the incidence of 14 cancer types has risen among people under age 50, while 19 other cancer types…
AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from Histopathology | CBIIT
Attend this Data Science Seminar to learn how a new deep learning approach predicts spatial gene expression and is changing our understanding of tumor heterogeneity…
Synthetic and Systems Approaches to Interrogate Spatiotemporal Processes in Cancer (Overview) | Events Registration
Overview This series of virtual mini workshops will explore how synthetic and systems biology can advance our understanding of spatially defined processes in cancer. Each…
Side Effects of Cancer Treatment
Side effects are problems that occur when cancer treatment affects healthy tissues or organs. Learn about side effects caused by cancer treatment. Know what signs…
Using Lung Cancer Screening to Help with Smoking Cessation
A program that combines intensive counseling and cessation drugs was very effective at helping smokers being screened for lung cancer quit, a clinical trial finds.
Funding Opportunities | Innovative Molecular Analysis Technologies (IMAT) Program
NCI’s IMAT program has funding opportunities to support the development and maturation of novel technologies offering new capabilities for targeting or measuring the molecular and…
Louis M. Staudt, M.D., Ph.D.
Dr. Staudt pioneered the use of gene expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy. He defined…